EV Biotech key facts
- Developer of microbial production strains designed to predict optimal strain modifications, growth media supplementation and optimization.
- It has raised $5.8M.
- Notable investors include Creative Destruction Lab, Endless Frontier Labs, Blue Horizon Corporation, Noordelijke Ontwikkelings Maatschappij, RUG Ventures — 21 tracked in total.
- Status: Privately Held (backing).
Who backs EV Biotech
21+- ·The complete investor list: 21 names
- ·Watch EV Biotech: the Monday email on marks, rounds and moves
EV Biotech funding rounds
No funding rounds for EV Biotech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
EV Biotech investors
21 investors are on record for EV Biotech, including Creative Destruction Lab, Endless Frontier Labs, Blue Horizon Corporation and Noordelijke Ontwikkelings Maatschappij.
About EV Biotech
Developer of microbial production strains designed to predict optimal strain modifications, growth media supplementation and optimization. The company solves the issue of pollution-heavy manufacturing methods by harnessing the power of fermentation combined with computational methods and leverages microbiology, genetic engineering and system biology to develop chemical compounds, enabling industrial clients to meet desired and personalized biochemical requirements.
- Sector
- Healthcare
- HQ
- Groningen, Netherlands
- Founded
- 2018
- Employees
- 14
- Website
- evbio.tech/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
EV Biotech doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.